Reply to D’Alessandro-Gabazza et al.: Risks of Treating Idiopathic Pulmonary Fibrosis with a TAM Receptor Kinase Inhibitor

Lignende værker

• Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis
  af: Espindola, Milena S., et al.
  Udgivet: (2018)
• Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice
  af: Habiel, David M., et al.
  Udgivet: (2018)
• Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis
  af: Habiel, David M., et al.
  Udgivet: (2014)
• Characterization of CD28(null) T cells in Idiopathic Pulmonary Fibrosis
  af: Habiel, David M, et al.
  Udgivet: (2018)
• Host–Microbial Interactions: Idiopathic Pulmonary Fibrosis in Technicolor
  af: O’Dwyer, David N., et al.
  Udgivet: (2017)